3628 results for «2221»

Filter By

3628 results

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

High thrombus burden in STEMI

22 May 2025 – From EuroPCR 2025

This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.

High thrombus burden in STEMI

Innovative strategies for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...

Innovative strategies for coronary interventions

Artificial intelligence in the cathlab

22 May 2025 – From EuroPCR 2025

Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.

Artificial intelligence in the cathlab

Emerging indications for TAVI in 2025

22 May 2025 – From EuroPCR 2025

Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.

Emerging indications for TAVI in 2025

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

22 May 2025 – From EuroPCR 2025

Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

Risk stratification of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...

Risk stratification of NSTEMI patients

TAVI in women

22 May 2025 – From EuroPCR 2025

Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...

TAVI in women

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

Innovations in transcatheter aortic valve devices and techniques

22 May 2025 – From EuroPCR 2025

Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...

Innovations in transcatheter aortic valve devices and techniques

When things threaten to go wrong: navigating procedural complications

22 May 2025 – From EuroPCR 2025

Develop critical skills for managing procedural complications in interventional cardiology. This session focuses on the identification and real-time management of common adverse events such as coronary dissection, perforation, tamponade, and embolism. Learn how to utilize echocardiographic imaging to assist in complication recognition and support your team...

When things threaten to go wrong: navigating procedural complications

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

TAVI - Outcomes predictors

22 May 2025 – From EuroPCR 2025

Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.

TAVI - Outcomes predictors

Difficult decision-making in left main revascularisation

22 May 2025 – From EuroPCR 2025

Address difficult clinical decisions in left main coronary artery revascularization through this session featuring complex cases. Topics include prioritization in combined left main, aortic valve disease, and low ejection fraction, management of myocardial infarction with severe mitral regurgitation and cardiogenic shock, and unique cases such as...

Difficult decision-making in left main revascularisation

Retrograde removal of the broken sheath

22 May 2025 – From EuroPCR 2025

This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.

Retrograde removal of the broken sheath

Impact of imaging in treatment of bifurcation lesions - Part 1

22 May 2025 – From EuroPCR 2025

Investigate the critical role of intracoronary imaging in the management of bifurcation lesions. This session addresses challenges such as difficult side branch access and lesion complexity, highlighting the importance of strategy over chance. Learn from cases focusing on left main bifurcation, lesion de-calibration, and complex ostial...

Impact of imaging in treatment of bifurcation lesions - Part 1

TAVI for aortic regurgitation off label

22 May 2025 – From EuroPCR 2025

Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.

TAVI for aortic regurgitation off label

Refine diagnosis to improve chronic heart failure care

22 May 2025 – From EuroPCR 2025

Refine diagnostic approaches to improve care in chronic heart failure patients. This session covers comparative pulmonary flow measurement techniques, prognostic significance of left atrial strain in mildly reduced ejection fraction, and serum interleukin-33 associations. Additionally, it reviews biopsy sheath contact confirmation during right ventricular biopsy and...

Refine diagnosis to improve chronic heart failure care

Acute complications during distal left main PCI - Part 3

22 May 2025 – From EuroPCR 2025

This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.

Acute complications during distal left main PCI - Part 3

Intracoronary image interpretation: from operator to artificial intelligence

22 May 2025 – From EuroPCR 2025

Explore the evolving landscape of intracoronary image interpretation from operator-dependent assessments to artificial intelligence (AI) assistance. This session features variability analysis between novices and experts in OCT interpretation, AI-driven plaque segmentation and quantification, comparisons of stent expansion assessments by core labs and AI software, and insights...

Intracoronary image interpretation: from operator to artificial intelligence
Didn’t find what you were looking for?